These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17667254)

  • 1. Levosimendan: right for the right ventricle?
    Lambermont B; Ghuysen A; Harstein G; D'Orio V
    Crit Care Med; 2007 Aug; 35(8):1995-6. PubMed ID: 17667254
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure.
    Kerbaul F; Gariboldi V; Giorgi R; Mekkaoui C; Guieu R; Fesler P; Gouin F; Brimioulle S; Collart F
    Crit Care Med; 2007 Aug; 35(8):1948-54. PubMed ID: 17568324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 4. Levosimendan: a new option in acute cardiac failure.
    Holley AD; Ziegenfuss M
    Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
    [No Abstract]   [Full Text] [Related]  

  • 5. Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
    Russ MA; Prondzinsky R; Christoph A; Schlitt A; Buerke U; Söffker G; Lemm H; Swyter M; Wegener N; Winkler M; Carter JM; Reith S; Werdan K; Buerke M
    Crit Care Med; 2007 Dec; 35(12):2732-9. PubMed ID: 17893627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction.
    Beute J
    Crit Care Med; 2009 Sep; 37(9):2678; author reply 2678-9. PubMed ID: 19687655
    [No Abstract]   [Full Text] [Related]  

  • 7. [Levosimendan for treatment of heart failure].
    Yasumura Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():169-72. PubMed ID: 17571380
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of levosimendan for treatment of cardiogenic shock associated with electrical storm.
    Grazi M; Lauri G; Carbucicchio C; Marenzi G
    Ann Intern Med; 2009 May; 150(10):738-40. PubMed ID: 19451590
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of levosimendan in Takotsubo-related cardiogenic shock.
    Antonini M; Stazi GV; Cirasa MT; Garotto G; Frustaci A
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):119-20. PubMed ID: 19961441
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome.
    De Santis V; Vitale D; Tritapepe L; Greco C; Pietropaoli P
    Ann Intern Med; 2008 Sep; 149(5):365-7. PubMed ID: 18765717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
    Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful use of levosimendan in a patient with cardiogenic shock complicating acute myocardial infarction].
    Mustapha F; Moufida H; Nedia B; Anis L; Iheb L; Habib H
    Tunis Med; 2005 Oct; 83(10):635-7. PubMed ID: 16370217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan in cardiogenic shock: better than enoximone!
    Buerke M; Prondzinsky R
    Crit Care Med; 2008 Aug; 36(8):2450-1. PubMed ID: 18664796
    [No Abstract]   [Full Text] [Related]  

  • 15. Levosimendan or enoximone in refractory cardiogenic shock?
    Berthelsen PG
    Crit Care Med; 2009 Mar; 37(3):1182. PubMed ID: 19237971
    [No Abstract]   [Full Text] [Related]  

  • 16. BET 1: Levosimendan in cardiogenic shock secondary to acute myocardial infarction.
    Emerg Med J; 2013 Dec; 30(12):1060-2. PubMed ID: 24232006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan in acute pulmonary embolism.
    Powell BP; Simes D
    Anaesth Intensive Care; 2007 Oct; 35(5):771-2. PubMed ID: 17933166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock.
    Guarracino F; Landoni G; Baldassarri R; Nobile L; Stefani M
    Br J Anaesth; 2010 Mar; 104(3):388-9. PubMed ID: 20150349
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of 30-day mortality of levosimendan versus enoximone.
    Rijnders BJ
    Crit Care Med; 2009 Mar; 37(3):1181-2. PubMed ID: 19237968
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence-based use of levosimendan in different clinical settings.
    De Luca L; Colucci WS; Nieminen MS; Massie BM; Gheorghiade M
    Eur Heart J; 2006 Aug; 27(16):1908-20. PubMed ID: 16682381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.